Quoin Pharmaceuticals (QNRX) Competitors $7.52 -0.10 (-1.31%) Closing price 09/5/2025 03:58 PM EasternExtended Trading$7.18 -0.34 (-4.51%) As of 09/5/2025 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QNRX vs. NXL, ALUR, OSRH, NVNO, IINN, BTCY, INBS, MHUA, FEMY, and SINTShould you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include Nexalin Technology (NXL), Allurion Technologies (ALUR), OSR (OSRH), enVVeno Medical (NVNO), Inspira Technologies OXY B.H.N. (IINN), Biotricity (BTCY), Intelligent Bio Solutions (INBS), Meihua International Medical Technologies (MHUA), Femasys (FEMY), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. Quoin Pharmaceuticals vs. Its Competitors Nexalin Technology Allurion Technologies OSR enVVeno Medical Inspira Technologies OXY B.H.N. Biotricity Intelligent Bio Solutions Meihua International Medical Technologies Femasys Sintx Technologies Quoin Pharmaceuticals (NASDAQ:QNRX) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership. Which has better valuation and earnings, QNRX or NXL? Nexalin Technology has higher revenue and earnings than Quoin Pharmaceuticals. Nexalin Technology is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuoin PharmaceuticalsN/AN/A-$8.96M-$41.45-0.18Nexalin Technology$170K85.68-$7.61M-$0.76-1.10 Do institutionals and insiders hold more shares of QNRX or NXL? 8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 13.5% of Quoin Pharmaceuticals shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is QNRX or NXL more profitable? Quoin Pharmaceuticals has a net margin of 0.00% compared to Nexalin Technology's net margin of -5,057.14%. Nexalin Technology's return on equity of -209.20% beat Quoin Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Quoin PharmaceuticalsN/A -210.50% -99.41% Nexalin Technology -5,057.14%-209.20%-186.87% Does the media refer more to QNRX or NXL? In the previous week, Quoin Pharmaceuticals had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 2 mentions for Quoin Pharmaceuticals and 1 mentions for Nexalin Technology. Quoin Pharmaceuticals' average media sentiment score of 0.50 beat Nexalin Technology's score of -1.00 indicating that Quoin Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Quoin Pharmaceuticals Positive Nexalin Technology Negative Which has more risk & volatility, QNRX or NXL? Quoin Pharmaceuticals has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.68, suggesting that its stock price is 268% more volatile than the S&P 500. Do analysts recommend QNRX or NXL? Nexalin Technology has a consensus price target of $5.00, suggesting a potential upside of 498.01%. Given Nexalin Technology's stronger consensus rating and higher possible upside, analysts plainly believe Nexalin Technology is more favorable than Quoin Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNexalin Technology beats Quoin Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNRX vs. The Competition Export to ExcelMetricQuoin PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.45M$2.60B$5.83B$9.93BDividend YieldN/A50.05%6.70%4.52%P/E Ratio-0.1823.3576.1526.11Price / SalesN/A754.04562.61123.62Price / CashN/A166.6036.9959.28Price / Book0.215.5011.486.09Net Income-$8.96M$32.95M$3.29B$266.51M7 Day Performance-1.97%2.88%1.27%0.46%1 Month Performance3.78%8.63%7.94%4.59%1 Year Performance-72.09%1.88%62.94%26.04% Quoin Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNRXQuoin Pharmaceuticals1.6175 of 5 stars$7.52-1.3%N/A-73.1%$4.45MN/A-0.184Short Interest ↓NXLNexalin Technology1.8512 of 5 stars$0.94-1.6%$5.00+431.2%-1.6%$16.39M$174.81K-1.243Negative NewsShort Interest ↑ALURAllurion Technologies3.2497 of 5 stars$2.09-3.9%$22.83+995.1%-86.0%$16.18M$32.11M-0.17501Positive NewsShort Interest ↓Analyst RevisionOSRHOSRN/A$0.72-6.7%N/AN/A$15.63M$104.74K0.00N/ANVNOenVVeno Medical1.638 of 5 stars$0.81+1.4%N/A-85.0%$15.61MN/A-0.6830High Trading VolumeIINNInspira Technologies OXY B.H.N.2.9243 of 5 stars$1.18+2.6%$2.00+69.5%+8.0%$14.89MN/A0.0020Short Interest ↓Analyst RevisionBTCYBiotricityN/A$0.58+7.2%N/A+73.4%$14.42M$12.06M-0.5440Gap UpINBSIntelligent Bio Solutions0.2449 of 5 stars$1.59-1.9%N/A+20.2%$14.28M$3.05M-0.7810Analyst DowngradeMHUAMeihua International Medical Technologies1.5701 of 5 stars$0.42-0.2%N/A-64.9%$13.37M$96.91M0.00620Short Interest ↓FEMYFemasys3.5531 of 5 stars$0.40+12.6%$7.33+1,733.3%-65.8%$13.03M$1.89M-0.4730Short Interest ↓High Trading VolumeSINTSintx Technologies2.4429 of 5 stars$4.57+10.1%$28.00+512.7%+86.1%$12.61M$2.89M-0.0940News CoverageShort Interest ↓Gap Down Related Companies and Tools Related Companies NXL Competitors ALUR Competitors OSRH Competitors NVNO Competitors IINN Competitors BTCY Competitors INBS Competitors MHUA Competitors FEMY Competitors SINT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNRX) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredHamilton’s 100-to-1 tradePorter Stansberry has made a career out of bold calls that go against the mainstream narrative — from the 1998...Porter & Company | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
